Cargando…

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018

INTRODUCTION: In contrast to countries where carbapenemase-producing Enterobacterales (CPE) are endemic, only sporadic cases were reported in Switzerland until 2013. An aggravation of the epidemiological situation in neighbouring European countries indicated the need for a surveillance study in Swit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramette, Alban, Gasser, Michael, Nordmann, Patrice, Zbinden, Reinhard, Schrenzel, Jacques, Perisa, Damir, Kronenberg, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167416/
https://www.ncbi.nlm.nih.gov/pubmed/33860749
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.1900760
_version_ 1783701687266967552
author Ramette, Alban
Gasser, Michael
Nordmann, Patrice
Zbinden, Reinhard
Schrenzel, Jacques
Perisa, Damir
Kronenberg, Andreas
author_facet Ramette, Alban
Gasser, Michael
Nordmann, Patrice
Zbinden, Reinhard
Schrenzel, Jacques
Perisa, Damir
Kronenberg, Andreas
author_sort Ramette, Alban
collection PubMed
description INTRODUCTION: In contrast to countries where carbapenemase-producing Enterobacterales (CPE) are endemic, only sporadic cases were reported in Switzerland until 2013. An aggravation of the epidemiological situation in neighbouring European countries indicated the need for a surveillance study in Switzerland. AIM: We aimed to describe CPE distributions in Switzerland and identify epidemiological factors associated with changes in incidence. METHODS: Data on all human CPE isolates from 2013 to 2018 were collected by the Swiss Centre for Antibiotic Resistance (ANRESIS) and analysed for temporal and regional trends by Generalised Poisson regression. Isolates associated with infection or colonisation were included in a primary analysis; a secondary analysis included invasive isolates only. Statistical detection of regional clusters was performed with WHONET/SaTScan. RESULTS: We analysed 731 CPE isolates, of which 325 (44.5%) were associated with screenings and 173 (23.7%) with infections. Yearly detection of CPE isolates increased considerably during the study period from 65 to 212. The most frequently isolated species were Klebsiella pneumoniae (54%) and Escherichia coli (28%). The most frequent genotypes were OXA-48 (43%), KPC (21%) and NDM (14%). In contrast to the French-speaking parts of Switzerland (West, Geneva) where OXA-48 were the predominant genotypes (around 60%), KPC was the most frequently detected genotype in the Italian-speaking region (63%). WHONET/SaTScan outbreak detection analysis identified seven clusters in five regions of Switzerland. CONCLUSIONS: In a first continuous surveillance of CPE in Switzerland, we found that the epidemiological situation aggravated nationwide and that regional patterns of CPE genotypes mirrored the situation in neighbouring European countries.
format Online
Article
Text
id pubmed-8167416
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-81674162021-06-04 Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018 Ramette, Alban Gasser, Michael Nordmann, Patrice Zbinden, Reinhard Schrenzel, Jacques Perisa, Damir Kronenberg, Andreas Euro Surveill Surveillance INTRODUCTION: In contrast to countries where carbapenemase-producing Enterobacterales (CPE) are endemic, only sporadic cases were reported in Switzerland until 2013. An aggravation of the epidemiological situation in neighbouring European countries indicated the need for a surveillance study in Switzerland. AIM: We aimed to describe CPE distributions in Switzerland and identify epidemiological factors associated with changes in incidence. METHODS: Data on all human CPE isolates from 2013 to 2018 were collected by the Swiss Centre for Antibiotic Resistance (ANRESIS) and analysed for temporal and regional trends by Generalised Poisson regression. Isolates associated with infection or colonisation were included in a primary analysis; a secondary analysis included invasive isolates only. Statistical detection of regional clusters was performed with WHONET/SaTScan. RESULTS: We analysed 731 CPE isolates, of which 325 (44.5%) were associated with screenings and 173 (23.7%) with infections. Yearly detection of CPE isolates increased considerably during the study period from 65 to 212. The most frequently isolated species were Klebsiella pneumoniae (54%) and Escherichia coli (28%). The most frequent genotypes were OXA-48 (43%), KPC (21%) and NDM (14%). In contrast to the French-speaking parts of Switzerland (West, Geneva) where OXA-48 were the predominant genotypes (around 60%), KPC was the most frequently detected genotype in the Italian-speaking region (63%). WHONET/SaTScan outbreak detection analysis identified seven clusters in five regions of Switzerland. CONCLUSIONS: In a first continuous surveillance of CPE in Switzerland, we found that the epidemiological situation aggravated nationwide and that regional patterns of CPE genotypes mirrored the situation in neighbouring European countries. European Centre for Disease Prevention and Control (ECDC) 2021-04-15 /pmc/articles/PMC8167416/ /pubmed/33860749 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.1900760 Text en This article is copyright of the authors or their affiliated institutions, 2020. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Surveillance
Ramette, Alban
Gasser, Michael
Nordmann, Patrice
Zbinden, Reinhard
Schrenzel, Jacques
Perisa, Damir
Kronenberg, Andreas
Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
title Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
title_full Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
title_fullStr Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
title_full_unstemmed Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
title_short Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
title_sort temporal and regional incidence of carbapenemase-producing enterobacterales, switzerland, 2013 to 2018
topic Surveillance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167416/
https://www.ncbi.nlm.nih.gov/pubmed/33860749
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.1900760
work_keys_str_mv AT ramettealban temporalandregionalincidenceofcarbapenemaseproducingenterobacteralesswitzerland2013to2018
AT gassermichael temporalandregionalincidenceofcarbapenemaseproducingenterobacteralesswitzerland2013to2018
AT nordmannpatrice temporalandregionalincidenceofcarbapenemaseproducingenterobacteralesswitzerland2013to2018
AT zbindenreinhard temporalandregionalincidenceofcarbapenemaseproducingenterobacteralesswitzerland2013to2018
AT schrenzeljacques temporalandregionalincidenceofcarbapenemaseproducingenterobacteralesswitzerland2013to2018
AT perisadamir temporalandregionalincidenceofcarbapenemaseproducingenterobacteralesswitzerland2013to2018
AT kronenbergandreas temporalandregionalincidenceofcarbapenemaseproducingenterobacteralesswitzerland2013to2018